Cedar Brook Financial Partners’s AbCellera Biologics ABCL Stock Holding History

Cedar Brook Financial Partners’s Portfolio ABCL Stock Details ABCL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$180K	Hold
2023 Q4	$216K	Buy
2023 Q3	$139K	Buy
2023 Q2	$163K	Buy
2023 Q1	$181K	Hold
2022 Q4	$243K	Buy
2022 Q3	$217K	Buy
2022 Q2	$223K	Buy
2022 Q1	$165K	Buy
2021 Q4	$168K	Buy